Generated by All in One SEO Pro v4.8.5, this is an llms.txt file, used by LLMs to index the site.

# HistoIndex

HistoIndex

## Sitemaps

- [XML Sitemap](https://histoindex.com/sitemap.xml): Contains all public/indexable URLs for this website.

## Posts

- [Blog](https://histoindex.com/blog/)
- [Newsletter May and June 2026](https://histoindex.com/newsletters/newsletter-may-and-june-2026/)
- [AI-Powered Analysis by HistoIndex Reveals Robust Liver Fibrosis Improvement with D&D Pharmatech’s Zabopegdutide in Phase 2 MASH Trial](https://histoindex.com/press-release/ai-powered-analysis-by-histoindex-reveals-robust-liver-fibrosis-improvement-with-dd-pharmatechs-zabopegdutide-in-phase-2-mash-trial/)
- [CLINICAL SPOTLIGHT: NITs Fail in Identifying Patients Eligible for Approved MASH Treatments](https://histoindex.com/blog/clinical-spotlight-nits-fail-in-identifying-patients-eligible-for-approved-mash-treatments/)
- [Newsletter January 2026](https://histoindex.com/newsletters/january-newsletter/)
- [Newsletter February 2026](https://histoindex.com/newsletters/newsletter-february-2026/)
- [Newsletter March 2026](https://histoindex.com/newsletters/newsletter-march-2026/)
- [Newsletter April 2026](https://histoindex.com/newsletters/newsletter-april-2026/)
- [HistoIndex Extends Access To Its MASH Diagnostic Offering Through New Partnerships In Texas And California](https://histoindex.com/press-release/histoindex-extends-access-to-its-mash-diagnostic-offering-through-new-partnerships-in-texas-and-california/)
- [Scaling Precision in MASH Diagnostics: How AI-Powered Fibrosis Analysis Is Transforming Clinical Workflows](https://histoindex.com/blog/scaling-precision-in-mash-diagnostics-how-ai-powered-fibrosis-analysis-is-transforming-clinical-workflows/)
- [Challenges in MASH Diagnostics: Why Accuracy Matters More Than Ever](https://histoindex.com/blog/challenges-in-mash-diagnosis/)
- [HistoIndex Partners with Houston Research Institute to Expand Advanced MASH Diagnostic Services](https://histoindex.com/press-release/histoindex-partners-with-houston-research-institute-to-expand-advanced-mash-diagnostic-services/)
- [HistoIndex to debut FibroSIGHT™ Plus and showcase latest scientific findings at AASLD The Liver Meeting® 2025](https://histoindex.com/press-release/histoindex-to-debut-fibrosight-plus-and-showcase-latest-scientific-findings-at-aasld-the-liver-meeting-2025/)
- [HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment](https://histoindex.com/press-release/histoindex-marks-another-step-forward-with-fibrosight-plus-introducing-ai-based-quantitative-analysis-in-fibrosis-assessment/)
- [HistoIndex sets new standards in fibrosis diagnosis](https://histoindex.com/media-coverage/histoindex-wins-biospectrum-asia-pacific-bioscience-industry-emerging-company-of-the-year-2012/)
- [Zicom Group invests in Singapore growth phase medtech Histoindex](https://histoindex.com/media-coverage/zicom-group-invests-in-singapore-growth-phase-medtech-histoindex/)
- [Leading The Disruption Of Tissue Imaging](https://histoindex.com/media-coverage/leading-the-disruption-of-tissue-imaging/)
- [Exposing A Silent Killer: Liver Disease](https://histoindex.com/media-coverage/exposing-a-silent-killer-liver-disease/)
- [Forging New Paths In Cancer Diagnostics](https://histoindex.com/media-coverage/forging-new-paths-in-cancer-diagnostics/)
- [Southeast Asia's largest medical device maker ready to fund 'category disruptor' start-ups](https://histoindex.com/media-coverage/southeast-asias-largest-medical-device-maker-ready-to-fund-category-disruptor-start-ups/)

## Pages

- [Home](https://histoindex.com/)
- [AASLD 2026](https://histoindex.com/aasld-2026/)
- [Conferences](https://histoindex.com/conferences/)
- [Applications for MASH](https://histoindex.com/applications-for-mash/)
- [Our Team](https://histoindex.com/team/)
- [Integrated Services](https://histoindex.com/integrated-services/)
- [Research-Based Services](https://histoindex.com/research-based-services/)
- [FibroSIGHT™](https://histoindex.com/fibrosight/)
- [FibroSIGHT™ Plus](https://histoindex.com/fibrosight-plus/)
- [About](https://histoindex.com/about/)
- [Applications for Oncology - HistoOnco™](https://histoindex.com/applications-for-oncology-histoonco/)
- [qFibrosis®](https://histoindex.com/qfibrosis/)
- [Digital Pathology](https://histoindex.com/digital-pathology/)
- [Second Harmonic Generation](https://histoindex.com/second-harmonic-generation/)
- [Technology](https://histoindex.com/technology/)
- [Case Studies](https://histoindex.com/case-studies/)
- [Rezdiffra Case Study](https://histoindex.com/rezdiffra-case-study/)
- [Clinical Testing Services](https://histoindex.com/clinical-testing-services/)
- [SOLAR Conference 2026](https://histoindex.com/conferences/solar-conference-2026/)
- [New Posters](https://histoindex.com/posters/)

## Resources

- [Steatosis in Cirrhosis: A Prognostic Marker for Liver-Related Outcomes in Metabolic-Dysfunction Associated Steatotic Liver Disease](https://histoindex.com/resources/steatosis-in-cirrhosis-a-prognostic-marker-for-liver-related-outcomes-in-metabolic-dysfunction-associated-steatotic-liver-disease/)
- [AI digital pathology as a key tool providing in-depth understanding of the progression and regression of MASH and fibrosis in male mouse models](https://histoindex.com/resources/ai-digital-pathology-as-a-key-tool-providing-in-depth-understanding-of-the-progression-and-regression-of-mash-and-fibrosis-in-male-mouse-models/)
- [Real-World Insights in Designing SteatoStat: An End-to-End Deep Learning Pipeline for Hepatic Steatosis Quantification](https://histoindex.com/resources/real-world-insights-in-designing-steatostat-an-end-to-end-deep-learning-pipeline-for-hepatic-steatosis-quantification/)
- [The Asian Pacific Association of the Study of the Liver expert survey on artificial intelligence‐assisted reporting of liver histopathology in metabolic dysfunction associated fatty liver disease](https://histoindex.com/resources/the-asian-pacific-association-of-the-study-of-the-liver-expert-survey-on-artificial-intelligence‐assisted-reporting-of-liver-histopathology-in-metabolic-dysfunction-associated-fatty-liver-dise/)
- [AI-Derived Macrophage Density Reveals Hot and Cold Fibrosis Endotypes with Distinct Biomarker Profiles in Metabolic Dysfunction–Associated Steatohepatitis](https://histoindex.com/resources/ai-derived-macrophage-density-reveals-hot-and-cold-fibrosis-endotypes-with-distinct-biomarker-profiles-in-metabolic-dysfunction-associated-steatohepatitis/)
- [Impact of PNPLA3 p.I148M variant on qFibrosis-based collagen morphology in MASLD: analysis from Milan biobank cohort](https://histoindex.com/resources/impact-of-pnpla3-p-i148m-variant-on-qfibrosis-based-collagen-morphology-in-masld-analysis-from-milan-biobank-cohort/)
- [Efruxifermin improved digital pathology and noninvasive fibrosis measures in participants with MASH and advanced fibrosis or compensated cirrhosis: analysis of the HARMONY and SYMMETRY phase 2b trials](https://histoindex.com/resources/efruxifermin-improved-digital-pathology-and-noninvasive-fibrosis-measures-in-participants-with-mash-and-advanced-fibrosis-or-compensated-cirrhosis-analysis-of-the-harmony-and-symmetry-phase-2b-trials/)
- [Quantitative digital pathology reveals distinct fibrosis zonal patterns among subtypes of steatotic liver disease](https://histoindex.com/resources/quantitative-digital-pathology-reveals-distinct-fibrosis-zonal-patterns-among-subtypes-of-steatotic-liver-disease/)
- [Natural history and predictors of fibrosis progression in metabolic dysfunction-associated steatotic liver disease (MASLD) – Longitudinal cohort study with paired liver biopsies](https://histoindex.com/resources/natural-history-and-predictors-of-fibrosis-progression-in-metabolic-dysfunction-associated-steatotic-liver-disease-masld-longitudinal-cohort-study-with-paired-liver-biopsies/)
- [A spatial metabolic atlas of liver lipid metabolism and fibrosis in metabolic dysfunction-associated steatotic liver disease](https://histoindex.com/resources/a-spatial-metabolic-atlas-of-liver-lipid-metabolism-and-fibrosis-in-metabolic-dysfunction-associated-steatotic-liver-disease/)
- [Pemvidutide treatment led to fibrosis regression after 24 weeks in patients with metabolic dysfunction-associated steatohepatitis: quantitative digital pathology analysis from the IMPACT phase 2b, multicenter, randomized, placebo-controlled trial](https://histoindex.com/resources/pemvidutide-treatment-led-to-fibrosis-regression-after-24-weeks-in-patients-with-metabolic-dysfunction-associated-steatohepatitis-quantitative-digital-pathology-analysis-from-the-impact-phase-2b-mul/)
- [Artificial Intelligence-based qFibrosis with Second Harmonic Generation Uncovers Distinct Layer-specific Collagen Architecture in Crohn’s Disease Biopsies.](https://histoindex.com/resources/artificial-intelligence-based-qfibrosis-with-second-harmonic-generation-uncovers-distinct-layer-specific-collagen-architecture-in-crohns-disease-biopsies/)
- [Quantitative regression of qFibrosis with resmetirom: Exploratory histologic endpoints from the MAESTRO-NASH phase III clinical trial](https://histoindex.com/resources/quantitative-regression-of-qfibrosis-with-resmetirom-exploratory-histologic-endpoints-from-the-maestro-nash-phase-iii-clinical-trial/)
- [AI-assisted fibrosis scoring in MASH: Exploring pathologist decision-making with an SHG-based AI digital pathology tool](https://histoindex.com/resources/ai-assisted-fibrosis-scoring-in-mash-exploring-pathologist-decision-making-with-an-shg-based-ai-digital-pathology-tool/)
- [qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis](https://histoindex.com/resources/qfibs-an-automated-technique-for-quantitative-evaluation-of-fibrosis-inflammation-ballooning-and-steatosis-in-patients-with-nonalcoholic-steatohepatitis/)
- [Multicenter Prospective Cohort Study on Clinical Outcomes and Fibrosis Patterns in Biopsy-Proven Steatotic Liver Disease Subtypes](https://histoindex.com/resources/multicenter-prospective-cohort-study-on-clinical-outcomes-and-fibrosis-patterns-in-biopsy-proven-steatotic-liver-disease-subtypes/)
- [Use of Artificial Intelligence-Assisted Histopathology for Evaluation of Sex-Specific Progression and Regression of Hepatocellular Carcinoma Related to Metabolic Dysfunction-Associated Fatty Liver Disease](https://histoindex.com/resources/use-of-artificial-intelligence-assisted-histopathology-for-evaluation-of-sex-specific-progression-and-regression-of-hepatocellular-carcinoma-related-to-metabolic-dysfunction-associated-fatty-liver-dis/)
- [Evaluation of Spatial Collagen Morphometry in TNBC versus Non-TNBC Biopsies: A Cross-Sectional SHG/TPEF Imaging and AI-Based Analysis of Tumor and Non-Tumor Regions](https://histoindex.com/resources/https-histoindex-com-wp-content-uploads-2025-12-1369_tnbc-vs-non-tnbc-pdf/)
- [Region-Specific Collagen Morphometric Parameters in HER2+ Breast Cancer versus TNBC: Insights from SHG/TPE Imaging and AI-Based Analysis](https://histoindex.com/resources/https-histoindex-com-wp-content-uploads-2025-12-1377_-her2-vs-tnbc-pdf/)
- [The Relationship Between Non-Invasive Tests and Digital Pathology for Quantifying Liver Fibrosis in MASLD](https://histoindex.com/resources/the-relationship-between-non-invasive-tests-and-digital-pathology-for-quantifying-liver-fibrosis-in-masld/)

## Webinars and Podcasts

- [Dialogues on AI Digital Pathology Episode 4: Dr. Nikolai Naoumov -](https://histoindex.com/webinars-podcasts/full-podcast-episode-4-with-dr-nikolai-naoumov-dialogues-on-ai-digital-pathology/)
- [Maximizing the Value of Liver Biopsies for MASH Management in the Era of Novel FDA-Approved Therapies](https://histoindex.com/webinars-podcasts/maximizing-the-value-of-liver-biopsies-for-mash-management-in-the-era-of-novel-fda-approved-therapies/)
- [Surfing the MASH Podcast S6.E3: Drugs and Diagnostics Evolve as the FDA Devolves. Newsmakers: FibroSIGHT Brings Clinical Trial Analytics to Clinical Practice Use of Biopsy](https://histoindex.com/webinars-podcasts/surfing-nash-podcast-s4-e50-4-wrapping-up-2023-an-interview-with-dean-tai/)
- [EASL 2024 Panel Discussion: Liver Biopsies in MASH](https://histoindex.com/webinars-podcasts/easl-2024-panel-discussion-liver-biopsy-mash/)
- [Webcast: Fit-for-purpose: The Evolving Role of Liver Biopsies in MASH Clinical Trials and Patient Management](https://histoindex.com/webinars-podcasts/fit-for-purpose-role-liver-biopsies-in-mash-webcast/)
- [Surfing NASH Podcast: S4-E50.4 - Wrapping up 2023: An Interview with Dean Tai](https://histoindex.com/webinars-podcasts/ai-pathology-steatoic-liver-disease-interview-nash-tsunami/)
- [Webinar: Deciphering NASH - Fibrosis Dynamics in Cirrhotic Patients & Insights into Ballooned Hepatocytes Using AI](https://histoindex.com/webinars-podcasts/deciphering-nash-fibrosis-dynamics-in-cirrhotic-patients-insights-into-ballooned-hepatocytes-using-ai/)
- [Webinar: NASH Animal Models and their Clinical Relevance - Quantitative Histopathology of Hepatic Fibrosis](https://histoindex.com/webinars-podcasts/webinar-nash-animal-models-and-their-clinical-relevance-quantitative-histopathology-of-hepatic-fibrosis/)
- [Dialogues on AI Digital Pathology Episode 1:  Dr Stephen Harrison](https://histoindex.com/webinars-podcasts/full-podcast-episode-1-with-dr-stephen-harrison-dialogues-on-ai-digital-pathology/)
- [Dialogues on AI Digital Pathology Episode 2: Dr. David Kleiner and Dr Dean Tai -](https://histoindex.com/webinars-podcasts/full-podcast-episode-2-with-dr-david-kleiner-feat-dr-dean-tai-dialogues-on-ai-digital-pathology/)
- [Dialogues on AI Digital Pathology Episode 3: Dr. Suneil Hosmane](https://histoindex.com/webinars-podcasts/full-podcast-episode-3-with-dr-suneil-hosmane-dialogues-on-ai-digital-pathology/)
- [Conversation with Thought Leaders Special Episode (Part 1)](https://histoindex.com/webinars-podcasts/full-podcast-special-episode-part-1-conversation-with-kol-liver-pathologists/)
- [Conversation with Thought Leaders Special Episode (Part 2)](https://histoindex.com/webinars-podcasts/full-podcast-special-episode-part-2-conversation-with-kol-liver-pathologists/)
- [Conversation with Thought Leaders Special Episode (Part 3)](https://histoindex.com/webinars-podcasts/full-podcast-special-episode-part-3-conversation-with-kol-hepatologists-and-pharma-thought-leaders-in-nash/)
- [Conversation with Thought Leaders Special Episode (Part 4)](https://histoindex.com/webinars-podcasts/full-podcast-special-episode-part-4-conversation-with-kol-hepatologists-and-pharma-thought-leaders-in-nash/)
- [Webinar: Deciphering NASH - Revealing the Unrevealed in Stain-free Biopsies](https://histoindex.com/webinars-podcasts/webinar-deciphering-nash-revealing-the-unrevealed-in-stain-free-biopsies/)
- [Digital Pathology Today: Season 2, Episode 16 - The World’s First Fully Automated, Quantitative, Stain-Free Imaging System](https://histoindex.com/webinars-podcasts/digital-pathology-today-season-2-episode-16-the-worlds-first-fully-automated-quantitative-stain-free-imaging-system/)
- [Surfing NASH Podcast: S3-E14 – NAS Scores And The Challenge Of Complex Balloon Hepatocytes](https://histoindex.com/webinars-podcasts/surfing-the-nash-tsunami-podcast-s3-e14-nas-scores-and-the-challenge-of-complex-balloon-hepatocytes/)
- [Surfing NASH Podcast: S4-E3.6 - Interview with Co-founder & CSO of HistoIndex, Dean Tai, on AI-Assisted Histology](https://histoindex.com/webinars-podcasts/interview-with-co-founder-cso-of-histoindex-dean-tai-on-ai-assisted-histology/)
- [Surfing NASH Podcast: S4-E27 - EASL Congress 2023 Preview: Heavy-Hitting Abstracts](https://histoindex.com/webinars-podcasts/surfing-the-nash-tsunami-podcast-s4-e27-easl-congress-2023-preview-heavy-hitting-abstracts/)

## Categories

- [Press Release](https://histoindex.com/category/press-release/)
- [Media Coverage](https://histoindex.com/category/media-coverage/)
- [Leadership](https://histoindex.com/category/leadership/)
- [Blog](https://histoindex.com/category/blog/)
- [Newsletters](https://histoindex.com/category/newsletters/)

## Tags

- [quantitative pathology analysis](https://histoindex.com/tag/quantitative-pathology-analysis/)
- [pathology](https://histoindex.com/tag/pathology/)
- [drug development](https://histoindex.com/tag/drug-development/)
- [patient treatment](https://histoindex.com/tag/patient-treatment/)
- [technology](https://histoindex.com/tag/technology/)
- [fibrosis](https://histoindex.com/tag/fibrosis/)
- [liver fibrosis](https://histoindex.com/tag/liver-fibrosis/)
- [imaging](https://histoindex.com/tag/imaging/)
- [ai pathology](https://histoindex.com/tag/ai-pathology/)
- [NAFLD](https://histoindex.com/tag/nafld/)
- [MASHD](https://histoindex.com/tag/mashd/)
- [glp-1 agonists](https://histoindex.com/tag/glp-1-agonists/)
- [mash](https://histoindex.com/tag/mash/)
- [metabolic health](https://histoindex.com/tag/metabolic-health/)
- [stain-free imaging](https://histoindex.com/tag/stain-free-imaging/)
- [histopathology](https://histoindex.com/tag/histopathology/)
- [second harmonic generation](https://histoindex.com/tag/second-harmonic-generation/)
- [shg](https://histoindex.com/tag/shg/)
- [digital pathology](https://histoindex.com/tag/digital-pathology/)
- [MASH diagnosis](https://histoindex.com/tag/mash-diagnosis/)

## Categories

- [Posters and abstracts](https://histoindex.com/categories/posters/)
- [Publications](https://histoindex.com/categories/publications/)
- [AASLD 2024](https://histoindex.com/categories/aasld-2024-posters/)
- [EASL 2024](https://histoindex.com/categories/easl-2024-posters/)
- [AASLD 2023](https://histoindex.com/categories/aasld-2023-posters/)
- [Paris NASH Meeting 2023](https://histoindex.com/categories/paris-nash-meeting-2023/)
- [EASL 2023](https://histoindex.com/categories/easl-2023-posters/)
- [EASL 2025](https://histoindex.com/categories/easl-2025/)
- [AASLD 2025](https://histoindex.com/categories/aasld-2025-posters/)
- [EASL 2025](https://histoindex.com/categories/easl-2025-2/)
- [SABCS 2025](https://histoindex.com/categories/sabcs-2025/)
- [DDW2026](https://histoindex.com/categories/ddw2026/)
- [EASL 2026](https://histoindex.com/categories/easl-2026/)